4.7 Letter

Outcome prediction in myelodysplastic neoplasm undergoing hematopoietic cell transplant in the molecular era of IPSS-M

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Education, Scientific Disciplines

Have we reached a molecular era in myelodysplastic syndromes?

Maria Teresa Voso et al.

Summary: Myelodysplastic syndromes (MDS) exhibit diverse biological and clinical features, with mutated genes playing a crucial role in diagnosis and prognosis. Specific mutations, such as SF3B1, can aid in defining MDS while others may indicate a poor prognosis. The incorporation of mutation profiles into prognostic systems can lead to more precise disease stratification and guide treatment decisions.

HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM (2021)

Article Medicine, General & Internal

Prognostic Mutations in Myelodysplastic Syndrome after Stem-Cell Transplantation

R. C. Lindsley et al.

NEW ENGLAND JOURNAL OF MEDICINE (2017)